Business
Imagion (ASX:IBX) share price up 1,166% in a year pursuing ‘radiation-free’ cancer tech
The Imagion Biosystems Ltd (ASX: IBX) share price has rocketed 1,166% over the past 12 months due to a series of promising projects around cancer detection.
The company’s bio is truly a mouthful: its principal business activities consist of nanotechnology, biotechnology, cancer diagnostics, and – the clincher — superparamagnetic relaxometry.
What investors should know is that it develops medical devices focused around cancer screening technology.
Imagion’s Magsense cancer screening technology
One of these tech projects, called Magsense, is a diagnostic imaging tool that can potentially increase…
-
Business22 hours agoWhy Auckland Airport, Australian Ethical, Breville, and Clarity shares are charging higher
-
Business23 hours agoMacquarie increases price target for Qantas shares
-
Noosa News24 hours agoHoyts Is Set to Launch Up to Five New IMAX Screens in Australia — Including at Melbourne Central Before the End of 2025
-
Noosa News22 hours agoCommonwealth Bank executive Christopher James McCann found dead in Springbrook National Park